Endo Pharma (ENDP) September volatility at 30, January at 35; shares near 32-month high
Endo Pharmaceuticals (Nasdaq: ENDP) is recently up $1.70 to $27.84. ENDP announced on August 9th an agreement to acquire all outstanding shares of Penwest Pharmaceuticals (Nasdaq: PPCO) for $5.00 in cash per share. Jefferies has a Buy rating on ENDP. September option implied volatility is at 30, October is at 31, January is at 35; verses its six-month average of 30 according to Track Data. Paul Foster
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Siliconware Precision (SPIL) Shares Drop on Volatility Spike
- Vodafone (VOD) Volatility Pops Early, Shares Inch Higher
- DryShips (DRYS) Trading Higher on Volatility, New Analyst Coverage
Create E-mail Alert Related Categories
OptionsRelated Entities
Jefferies & Co, OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
